Cargando…
Corrigendum: Coexpression of HHLA2 and PD-L1 on tumor cells independently predicts the survival of spinal chordoma patients
Autores principales: | Xia, Chao, Huang, Wei, Chen, Yun-Liang, Fu, Hai-Bin, Tang, Ming, Zhang, Tao-Lan, Li, Jing, Lv, Guo-Hua, Yan, Yi-Guo, Ouyang, Zhi-Hua, Yao, Nvzhao, Wang, Cheng, Zou, Ming-Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140679/ https://www.ncbi.nlm.nih.gov/pubmed/37122699 http://dx.doi.org/10.3389/fimmu.2023.1194064 |
Ejemplares similares
-
Coexpression of HHLA2 and PD-L1 on Tumor Cells Independently Predicts the Survival of Spinal Chordoma Patients
por: Xia, Chao, et al.
Publicado: (2022) -
Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020) -
A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma
por: Zou, Ming‐Xiang, et al.
Publicado: (2020) -
Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison With Conventional Chordomas
por: Liu, Fu-Sheng, et al.
Publicado: (2021) -
KIR3DL3-HHLA2 and TMIGD2-HHLA2 pathways: The dual role of HHLA2 in immune responses and its potential therapeutic approach for cancer immunotherapy
por: Li, Yang, et al.
Publicado: (2022)